Introduction
Numbers of patients suffering from allergic diseases, such as asthma, pollenosis, atopic dermatitis, etc. have been increased in industrially advanced countries. The increases are remarkable especially in urban area in such countries. It has been generally accepted that not only genetic but also environmental factors contribute to the pathogenesis of various diseases. Allergic diseases are also caused by both factors. Genetic factors can be explained by a concept of single nucleotide polymorphism (SNP), which means that only one nucleotide mutation can make a person highly sensitive to allergic diseases. However, the recent increase in the number of allergic patients cannot be explained merely by SNP. It has been widely indicated that environmental factors such as air pollution, improvement of hygiene, changes in foods and dwelling, etc. are closely associated with the increase in patients. In this chapter, the relationship between air pollutants and allergic diseases in the airway tissues is Focused on. In order to demonstrate this relationship, experimental animal models of allergic asthma have been widely utilized. First, the findings obtained from animal models are summarized. Second, we have actually evaluated whether the pyrenes present in diesel exhaust particles, cigarette smoke, etc. aggravate allergic rhinitis symptoms in a pollenosis guinea pig model (Mizutani et al., 2007) . The methodology of development of this model of pollenosis and the effects of pyrenes on the model are also described.
Air pollutants that have been demonstrated to aggravate airway allergic diseases in experimental animal models 421
Epidemiologic studies in asthmatics have reported an association between environmental cigarette smoke (ETS) exposure and asthma symptoms. In asthmatic children, parental smoking increases levels of asthma symptoms and the frequency of asthma exacerbations (Evans, 1987; Chilmonczyk, 1993; Britton, 2005) . In experimental animal models, chronic coexposure to ETS increased levels of allergen-induced airway remodelling and airway responsiveness by up-regulating the expression of chemokines (Min, 2007) , suggesting that ETS is a risk factor for asthma. Other studies using animal models have also reported that exposure to ETS aggravates airway allergy (Seymour, 1997 (Seymour, , 2003 (Seymour, , 2005 Rumold, 2001) , although there are also controversial reports (Kang, 1996; Boweles, 2005) . In contrast, the effect of mainstream or active cigarette smoking (MTS) on asthma is controversial. MTS has been associated with increased an serum level of IgE and airway hyprresponsiveness (Barbee, 1987; Mitsunobu, 2004) . However, other studies in asthmatic patients have failed to find any relationship between MTS and asthma (Siroux, 2000; Vidal, 2004) . Even in experimental animal models, the impact of MTS on OVA-induced asthmatic responses in mice is controversial (Robbins, 2005; Moerloose, 2005 Moerloose, , 2006 Thatcher, 2008) . Thus, the difference between the effects of ETS and MTS on asthma should be further analyzed in experimental studies.
Nanoparticles
The development of nano-technology has increased opportunities to be exposed to engineered nanomaterials present in the environment. Nanomaterials are included in industrially manufactured products such as ink, toner, cosmetics, latex, etc. However, it has been largely unclear how exposure to these nanomaterials affects human health, especially the airway tissues. Inoue et al. (2005 Inoue et al. ( , 2009a Inoue et al. ( , 2009b and others (Alessandrini, 2006; de Haar, 2008) have extensively studied the effects of nanoparticles on allergen-induced asthmatic responses in mice, reporting that relatively small diameters of particles induced enhancement of allergic airway inflammation. For example, nanoparticles with a diameter of 14 nm produced more prominent allergic airway inflammation, characterized by infiltration of eosinophils and neutrophils, by an increase in epithelial goblet cell number, and by increases in levels of cytokines and chemokines in the lung than those with a diameter of 56 nm. Further studies are required to fully understand the mechanisms underlying the aggravation of nanomaterials on the allergic airway inflammation.
Asian sand dust
Asian sand dust is a dust storm originating in the deserts of China and Mongolia, and heading toward Japan, Taiwan, Korea, etc. It has been recognized that Asian sand dust may be artificially formed by environmental deterioration such as deforestation, etc. The diameters of particles in sand dust are several to several tens of micrometers. Such coarse particles may have limited adverse effects on the respiratory organ. However, recent studies have indicated that Asian sand dust contains sulfates and nitrates (Ro, 2005 ) that may originate from industrial areas in China. In addition, it was reported that fungi are adsorbed to Asian sand dust (Ichinose, 2008a) . Ichinose et al. (2008b) first reported that exposure to Asian sand dust to OVA-sensitized mice enhanced allergen challenge-induced asthmatic responses including lung eosinophilia, Th2 cytokine and chemokine production in the lungs. More interestingly, they demonstrated that allergic rhinitis symptoms induced by Japanese cedar pollen in guinea pigs were also augmented by exposure to Asian sand dust (Ichinose, 2009 ). However, the relationship between Asian sand dust and health problems remains inconclusive, and further epidemiological and experimental studies are required.
Aggravation of allergic rhinitis by pyrenes: Demonstration by Japanese cedar pollen-induced allergic rhinitis model of guinea pigs
Pyrenes, such as benzo(a)pyrene (BaP) and 1-nitropyrene (1-NP), which are encountered in the environment mainly in the form of air pollution, are ubiquitous environmental pollutants found in DEP and cigarette smoke (Rosenkranz, 1980; Scheepers, 1995; Bai, 1998; Ohura, 2004) . Carcinogenic and mutagenic effects of BaP and 1-NP in various cell types have been well documented (Bai, 1998; el-Bayoumy, 1995; Nakanishi, 2000) . In addition, exposure to BaP enhances allergen-induced IgE and Th2 cytokine productions in mice Kadkohda, 2005) . As described above, analyses of the relationships between air pollutants and airway allergy have been conducted using asthmatic mouse models. Meanwhile, pollenosis is a major health problem in Japan because the proportion of people with pollenosis in this country has been estimated to be more than 30%. Although the allergic symptoms of pollenosis, such as rhinitis and conjunctivitis, are not life-threatening like the airway obstructive response in asthma, chronic nasal blockage considerably lowers the quality of life of pollenosis patients. In addition, the nasal tissue is the first organ that contacts not only allergens but also air pollutants. Furthermore, "global warming" could increase the quantity of pollen from trees; it was experimentally demonstrated that a doubling of the atmospheric CO 2 concentration significantly stimulated ragweed pollen production (Wayne, 2002) , suggesting that the health problem associated with pollens may be further exacerbated in future. Thus, the exposure effects of air pollutants on pollenosis should also be thoroughly examined.
We have established an experimental allergic rhinitis model in sensitized guinea pigs, using Japanese cedar pollen as the antigen (Nabe, 1997a (Nabe, , 1998 ). This experimental model has been used to assess whether short and long-term daily treatment with pyrenes, BaP and 1-NP aggravate antigen-induced sneezing and nasal blockage (Mizutani, 2007) .
Development of an allergic rhinitis model showing nasal blockage
Japanese cedar pollen is also an air pollutant in the spring in Japan, and the most prevalent pollenosis allergen in this country. Thus, we have used cedar pollen as an allergen for development of an animal model of allergic rhinitis.
To begin with, we attempted to develop an animal model of allergic rhinitis that clearly shows allergic nasal symptoms including sneezing and nasal blockage like the patients. The guinea pig has long been used as a species showing a high responder of bronchial smooth muscle to various endogenous molecules such as histamine, cysteinyl leukotirenes, etc. Thus, we and others have used guinea pigs as a model animal of allergic asthma (Hutson, 1988; Matsumoto, 1994; Nabe, 1997b) . From our experience of using of this species in asthma, we also used the guinea pig to develop an experimental model of allergic rhinitis. In a disease model that can be utilized for pharmacological examinations and analyses of pathogenesis of diseases, several important considerations arise as follows: 1) The model animal should clearly exhibit symptoms that are similar to patients with the disease and actually torment patients, 2) symptoms should be reproducibly caused by reproducible methods, 3) symptoms can be measured as quantitatively as possible.
To satisfy these points, as shown in Fig. 1 (upper panel) , guinea pigs were intranasally sensitized with the pollen extract+Al(OH) 3 , and then intranasally challenged by a quantitative inhalation of the pollen once a week for several months (Nabe, 1997a) . After the respective pollen challenge periods, the allergen-specific IgE antibody level in serum was measured, sneezing frequency was counted, and the degree of nasal blockage was assessed by measuring specific airway resistance (sRaw) using a double-flow plethysmograph system. Because a major antigen protein in Japanese cedar pollen is Cry j 1, the amount of Cry j 1specific IgE antibody in the serum was measured until the 29th challenge. Consequently, Cry j 1-specific IgE antibody level was increased during the repeated pollen challenges (Fig.  1, lower left panel) (Nabe, 1997a (Nabe, , 2005 . In addition, after respective pollen challenges, sneezing was induced within 1 h after a challenge (Nabe, 1998) . Regarding nasal blockage, both early and late phase nasal blockage were induced with their respective peaks at 1-2 h and 4-6 h after pollen challenges. The magnitude of biphasic nasal blockage was enhanced until the 7th challenge, followed by induction of almost reproducible nasal blockage after respective pollen challenges until around 30 challenges (Nabe, 1998) . Images of the timecourse of sneezing, and early and late phase nasal blockage after a certain challenge period are illustrated in the lower right panel of Fig. 1 . Induction of sneezing and biphasic nasal blockage was very similar to the symptoms of allergic rhinitis in pollenosis patients. Although nasal secretion is also a characteristic sign in the patients, and could be clearly observed in the model guinea pigs, we did not attempt to quantify the secretions. 
Aggravation of pollen-induced nasal blockage by BaP and 1-NP
As shown in Fig. 2 (upper panel) , guinea pigs that had been sensitized with pollen extract plus Al(OH) 3 were repeatedly challenged with the pollen once a week. From 6 days before the first sensitization, BaP (100 µg/10 µl per nostril) or 1-NP (10 µg/10 µl per nostril) was daily administered into both nostrils (Fig. 2, upper panel) . As expected, BaP aggravated both the early and late phase nasal blockage with statistical significance, and 1-NP also significantly enhanced the late phase response (Fig. 2, lower left and middle panels) . In contrast, neither sneezing frequency nor the increase in Cry j 1-specific IgE antibody were affected even by long-term treatment (Fig. 2 , lower right panel, and Table 2 ) (Mizutani, 2007) . Unexpectedly, a relatively short period (2 weeks) of treatment with BaP or 1-NP failed to significantly affect the magnitudes of early and late phase nasal blockage or the sneezing frequency (Mizutani, 2007) . We have reported that sneezing is mediated mainly by histamine that is released from the nasal mucosal mast cells via antigen-IgE antibody reaction (Yamasaki, 2001; Fukuda, 2003) . Our findings suggest that the pyrenes did not affect the antigen-IgE antibody reaction of mast cells. Meanwhile we have previously suggested that oxidative stress can be closely associated with the induction of biphasic nasal blockage (Mizutani, 2008) . As other studies have demonstrated that BaP induces an increase in oxidative stress (Jeng, 2010; Gao,2011) , the BaP-induced enhancement of nasal blockage may be due to increased oxidative stress. The aggravation of nasal blockage was reduced by cessation of the exposure to pyrenes in our model of pollenosis (Mizutani, 2007) , indicating that avoidance of air pollutants is an appropriate method for treating the allergy.
Amount of IgE (AU/ml) Vehicle 45.3±19.5
BaP 49.1±22.0 1-NP 32.9±11.5 Table 2 . Effects of benzo(a)pyrene (BaP) and 1-nitropyrene (1-NP) on the increase in Cry j 1specific IgE at the 13th pollen challenge in sensitized guinea pigs. Each value represents the mean±S.E. of 10 animals.
Conclusion
It has been experimentally demonstrated that air pollutants such as DEP, ROFA, cigarette smoke, nanoparticles, Asian sand dust, etc. can aggravate allergic disorders. Exposure to those environmental pollutants in genetically allergic persons could synergistically aggravate their allergic symptoms. In future, both epidemiological and experimental analyses of the relationships between all candidate pollutants and allergic diseases are further required. 
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